Related Experiment Video

Updated: May 11, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

[Management of atrial fibrillation comorbid with coronary heart disease]

Seiji Takatsuki1

  • 1Department of Cardiology, Keio University School of Medicine.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|May 2, 2013
PubMed

Insights

Managing atrial fibrillation (AF) and coronary artery disease (CAD) requires careful stroke prevention due to overlapping risk factors and increased bleeding risks. Rhythm control for AF may be limited, with K channel blockers often preferred in patients with CAD.

Area of Science:

  • Cardiology
  • Internal Medicine
  • Pharmacology

Context:

  • Atrial fibrillation (AF) and coronary artery disease (CAD) frequently coexist due to shared risk factors like aging and hypertension.
  • Managing stroke risk in patients with both AF and CAD presents unique challenges.
  • CAD is a recognized risk factor for stroke in AF patients, influencing risk stratification scores like CHA2DS2-VASc.

Purpose:

  • To outline the complexities in managing patients with comorbid AF and CAD.
  • To highlight the increased bleeding risks associated with combined antiplatelet and anticoagulant therapies.
  • To discuss limitations in AF rhythm control strategies when CAD is present.

Summary:

  • Patients with both AF and CAD often require dual therapies (antiplatelet and anticoagulant), increasing hemorrhage risk.
  • Rhythm control medications for AF may be contraindicated or limited in patients with CAD.
  • Potassium channel blockers are frequently considered first-line agents for rhythm control in AF patients with concurrent CAD.

Impact:

  • Informs clinical decision-making for stroke prevention in a complex patient population.
  • Guides pharmacotherapy selection to balance efficacy and safety (bleeding risk).
  • Emphasizes the need for individualized treatment plans considering both AF and CAD management.

More Related Videos

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China08:42

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China

Published on: February 11, 2022

Related Concept Videos

Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...